2,742 reports of this reaction
3.4% of all GOLD reports
#2 most reported adverse reaction
RHEUMATOID ARTHRITIS is the #2 most commonly reported adverse reaction for GOLD. There are 2,742 FDA adverse event reports linking GOLD to RHEUMATOID ARTHRITIS. This represents approximately 3.4% of all 79,992 adverse event reports for this drug.
Patients taking GOLD who experience rheumatoid arthritis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RHEUMATOID ARTHRITIS is moderately reported among GOLD users, representing a notable but not dominant share of adverse events.
In addition to rheumatoid arthritis, the following adverse reactions have been reported for GOLD:
The following drugs have also been linked to rheumatoid arthritis in FDA adverse event reports:
RHEUMATOID ARTHRITIS has been reported as an adverse event in 2,742 FDA reports for GOLD. This does not prove causation, but indicates an association observed in post-market surveillance data.
RHEUMATOID ARTHRITIS accounts for approximately 3.4% of all adverse event reports for GOLD, making it one of the most commonly reported side effect.
If you experience rheumatoid arthritis while taking GOLD, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.